PCM
GNMK

Pentwater Capital Management’s GenMark Diagnostics, Inc GNMK Stock Holding History

Pentwater Capital Management’s Portfolio GNMK Stock Details GNMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-391,819
Closed -$9.36M – 427
2021
Q1 		$9.36M Buy
+391,819
New +$7.28M 0.09% 84

Pentwater Capital Management's GNMK Position: Q2 2021 in Review

Pentwater Capital Management sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2021, closing a stake of 391,819 shares — an estimated $9.36M sold.

Pentwater Capital Management first reported a position in GNMK in Q1 2021 and held it in 1 quarter. The position peaked at $9.36M in Q1 2021. 0 funds tracked by Wall St. Rank hold GNMK as of Q2 2021.

  • Pentwater Capital Management reported no remaining GenMark Diagnostics, Inc position as of Q2 2021 after selling out during the quarter.
  • Pentwater Capital Management sold 391,819 GenMark Diagnostics, Inc shares in Q2 2021, an estimated $9.36M.
  • Pentwater Capital Management first reported a position in GenMark Diagnostics, Inc in Q1 2021 and held it in 1 quarter.
  • Pentwater Capital Management's GenMark Diagnostics, Inc position peaked at $9.36M in Q1 2021.
  • 0 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2021.

Based on Pentwater Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.